Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

USA - NYSE:NYT - US6501111073 - Common Stock

56.19 USD
+0.54 (+0.97%)
Last: 10/17/2025, 8:04:00 PM
56.19 USD
0 (0%)
After Hours: 10/17/2025, 8:04:00 PM
Fundamental Rating

7

Taking everything into account, NYT scores 7 out of 10 in our fundamental rating. NYT was compared to 95 industry peers in the Media industry. NYT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NYT is not valued too expensively and it also shows a decent growth rate. These ratings could make NYT a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NYT had positive earnings in the past year.
In the past year NYT had a positive cash flow from operations.
NYT had positive earnings in each of the past 5 years.
Each year in the past 5 years NYT had a positive operating cash flow.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

NYT's Return On Assets of 11.42% is amongst the best of the industry. NYT outperforms 94.68% of its industry peers.
NYT's Return On Equity of 16.55% is amongst the best of the industry. NYT outperforms 86.17% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.36%, NYT belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.
NYT had an Average Return On Invested Capital over the past 3 years of 11.43%. This is above the industry average of 8.50%.
The 3 year average ROIC (11.43%) for NYT is below the current ROIC(14.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROIC 14.36%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

NYT has a Profit Margin of 11.92%. This is amongst the best in the industry. NYT outperforms 84.04% of its industry peers.
In the last couple of years the Profit Margin of NYT has grown nicely.
NYT has a Operating Margin of 15.50%. This is amongst the best in the industry. NYT outperforms 81.91% of its industry peers.
NYT's Operating Margin has improved in the last couple of years.
NYT has a Gross Margin of 50.04%. This is comparable to the rest of the industry: NYT outperforms 56.38% of its industry peers.
NYT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

NYT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, NYT has less shares outstanding
The number of shares outstanding for NYT has been reduced compared to 5 years ago.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

NYT has an Altman-Z score of 9.08. This indicates that NYT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NYT (9.08) is better than 93.62% of its industry peers.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.08
ROIC/WACC1.66
WACC8.66%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.48 indicates that NYT should not have too much problems paying its short term obligations.
NYT's Current ratio of 1.48 is fine compared to the rest of the industry. NYT outperforms 62.77% of its industry peers.
NYT has a Quick Ratio of 1.48. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.48, NYT is doing good in the industry, outperforming 63.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

NYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.40%, which is quite impressive.
The Earnings Per Share has been growing by 16.92% on average over the past years. This is quite good.
The Revenue has been growing slightly by 7.82% in the past year.
Measured over the past years, NYT shows a small growth in Revenue. The Revenue has been growing by 7.37% on average per year.
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%

3.2 Future

NYT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.13% yearly.
The Revenue is expected to grow by 6.49% on average over the next years.
EPS Next Y18.39%
EPS Next 2Y12.53%
EPS Next 3Y12.43%
EPS Next 5Y13.13%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.08 indicates a quite expensive valuation of NYT.
NYT's Price/Earnings ratio is a bit cheaper when compared to the industry. NYT is cheaper than 64.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.42. NYT is around the same levels.
With a Price/Forward Earnings ratio of 22.08, NYT is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NYT is on the same level as its industry peers.
NYT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.08
Fwd PE 22.08
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYT is on the same level as its industry peers.
NYT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 20.1
EV/EBITDA 16.5
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NYT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NYT's earnings are expected to grow with 12.43% in the coming years.
PEG (NY)1.36
PEG (5Y)1.48
EPS Next 2Y12.53%
EPS Next 3Y12.43%

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.29%.
Compared to an average industry Dividend Yield of 4.46, NYT pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.29, NYT pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

On average, the dividend of NYT grows each year by 21.48%, which is quite nice.
NYT has been paying a dividend for at least 10 years, so it has a reliable track record.
NYT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)21.48%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NYT pays out 29.50% of its income as dividend. This is a sustainable payout ratio.
NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP29.5%
EPS Next 2Y12.53%
EPS Next 3Y12.43%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NEW YORK TIMES CO-A

NYSE:NYT (10/17/2025, 8:04:00 PM)

After market: 56.19 0 (0%)

56.19

+0.54 (+0.97%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners98.63%
Inst Owner Change-0.24%
Ins Owners0.61%
Ins Owner Change-0.16%
Market Cap9.15B
Analysts75
Price Target58.59 (4.27%)
Short Float %6.77%
Short Ratio5.84
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend0.5
Dividend Growth(5Y)21.48%
DP29.5%
Div Incr Years6
Div Non Decr Years11
Ex-Date10-08 2025-10-08 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.94%
Min EPS beat(2)15.73%
Max EPS beat(2)18.14%
EPS beat(4)4
Avg EPS beat(4)12.21%
Min EPS beat(4)6.49%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)19.88%
EPS beat(12)12
Avg EPS beat(12)28.39%
EPS beat(16)16
Avg EPS beat(16)25.56%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)1.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)1.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.34%
PT rev (1m)0%
PT rev (3m)2.58%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)9.17%
EPS NY rev (1m)1.29%
EPS NY rev (3m)7.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE 25.08
Fwd PE 22.08
P/S 3.4
P/FCF 20.1
P/OCF 18.67
P/B 4.73
P/tB 7.13
EV/EBITDA 16.5
EPS(TTM)2.24
EY3.99%
EPS(NY)2.55
Fwd EY4.53%
FCF(TTM)2.8
FCFY4.98%
OCF(TTM)3.01
OCFY5.36%
SpS16.51
BVpS11.89
TBVpS7.88
PEG (NY)1.36
PEG (5Y)1.48
Profitability
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROCE 18.71%
ROIC 14.36%
ROICexc 18.96%
ROICexgc 30.93%
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
FCFM 16.93%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
ROICexc(3y)14.65%
ROICexc(5y)14.2%
ROICexgc(3y)25.48%
ROICexgc(5y)21.57%
ROCE(3y)14.89%
ROCE(5y)13.67%
ROICexcg growth 3Y17%
ROICexcg growth 5Y17.39%
ROICexc growth 3Y3.36%
ROICexc growth 5Y8.52%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score9
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.07%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 97.77%
Profit Quality 142.1%
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 9.08
F-Score9
WACC8.66%
ROIC/WACC1.66
Cap/Depr(3y)35.41%
Cap/Depr(5y)44.4%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.45%
Profit Quality(3y)113.54%
Profit Quality(5y)142.07%
High Growth Momentum
Growth
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
EPS Next Y18.39%
EPS Next 2Y12.53%
EPS Next 3Y12.43%
EPS Next 5Y13.13%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%
Revenue Next Year7.96%
Revenue Next 2Y7.1%
Revenue Next 3Y6.62%
Revenue Next 5Y6.49%
EBIT growth 1Y22.62%
EBIT growth 3Y10.95%
EBIT growth 5Y15.46%
EBIT Next Year37.56%
EBIT Next 3Y18.17%
EBIT Next 5YN/A
FCF growth 1Y101.81%
FCF growth 3Y17.6%
FCF growth 5Y21.42%
OCF growth 1Y92.64%
OCF growth 3Y15.12%
OCF growth 5Y16.67%